CC
ATRA icon

Centiva Capital’s Atara Biotherapeutics ATRA Stock Holding History

Centiva Capital’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-43,403
Closed -$353K – 1675
2024
Q3 		$353K Sell
43,403
-96,847
-69% -$829K 0.02% 1478
2024
Q2 		$1.19M Buy
+140,250
New +$2.11M 0.06% 682
2023
Q3 		– Sell
-1,166
Closed -$46.9K – 1715
2023
Q2 		$46.9K Buy
+1,166
New +$65.9K ﹤0.01% 1508

Other funds holding ATRA

EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return